Dechert LLP’s global capital markets team stands out for its work involving business development companies (BDCs).
Thomas Friedmann in Boston represents both domestic and foreign issuers as well as investment banks in connection with public and private securities transactions. Philadelphia’s
Stephen Leitzell is especially active in the healthcare and tech sectors.
Harry Pangas in Washington DC is noted for his work for BDCs, registered closed-end funds, interval funds, and tender offer funds. The three partners lead the group along with New York-based
Anna Tomczyk.
David Rosenthal in New York has a strong track record advising corporations, investment banks, and venture capital firms operating in the life sciences space.